Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient.

ABSTRACT:

SUBMITTER: Gao X 

PROVIDER: S-EPMC12932409 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature